Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Fowler

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Circulation|February 15, 1996
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricleN P Lewis, P S Tsao, P R Rickenbacher, et al.
Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.
Circulation|March 15, 1996
Expression of inducible nitric oxide synthase in human heart failureG A Haywood, P S Tsao, H E von der Leyen, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examinationC V Leier, J B Young, T B Levine, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Circulation|February 15, 1996
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricleN P Lewis, P S Tsao, P R Rickenbacher, et al.
Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.
Circulation|March 15, 1996
Expression of inducible nitric oxide synthase in human heart failureG A Haywood, P S Tsao, H E von der Leyen, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examinationC V Leier, J B Young, T B Levine, et al.
Pageof 7